Liu Yanfang, Michael M Dodson, Kash Shera, Bensch William R, Monia Brett P, Murray Susan F, Otto Keith A, Syed Samreen K, Bhanot Sanjay, Sloop Kyle W, Sullivan John M, Reifel-Miller Anne
Type 2 Diabetes Drug Hunting Team, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA.
Endocrinology. 2007 Feb;148(2):683-92. doi: 10.1210/en.2006-0708. Epub 2006 Oct 26.
Adiponectin/adiponectin receptors (AdipoR) are involved in energy homeostasis and inflammatory pathways. To investigate the role of AdipoR2 in metabolic control, we studied the lipid and glucose metabolic phenotypes in AdipoR2-deficient mice. AdipoR2 deletion diminished high-fat diet-induced dyslipidemia and insulin resistance yet deteriorated glucose homeostasis as high-fat feeding continued, which resulted from the failure of pancreatic beta-cells to adequately compensate for the moderate insulin resistance. A defect in the AdipoR2 gene may represent a mechanism underlying the etiology of certain subgroups of type 2 diabetic patients who eventually develop overt diabetes, whereas other obese patients do not.
脂联素/脂联素受体(AdipoR)参与能量稳态和炎症信号通路。为了研究AdipoR2在代谢控制中的作用,我们对AdipoR2基因敲除小鼠的脂质和葡萄糖代谢表型进行了研究。敲除AdipoR2基因可减轻高脂饮食诱导的血脂异常和胰岛素抵抗,但随着高脂喂养的持续,葡萄糖稳态会恶化,这是由于胰岛β细胞无法充分代偿中度胰岛素抵抗所致。AdipoR2基因缺陷可能是某些最终发展为显性糖尿病的2型糖尿病患者亚组病因的潜在机制,而其他肥胖患者则不会出现这种情况。